{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:13:07Z","timestamp":1795029187672,"version":"4.10.2"},"reference-count":73,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:sec id=\"ab-yoi230002-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Cannabis use disorder (CUD) is increasing among US adults. Few national studies have addressed the role of medical cannabis laws (MCLs) and recreational cannabis laws (RCLs) in these increases, particularly in patient populations with high rates of CUD risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230002-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To quantify the role of MCL and RCL enactment in the increases in diagnosed CUD prevalence among Veterans Health Administration (VHA) patients from 2005 to 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230002-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Staggered-adoption difference-in-difference analyses were used to estimate the role of MCL and RCL in the increases in prevalence of CUD diagnoses, fitting a linear binomial regression model with fixed effects for state, categorical year, time-varying cannabis law status, state-level sociodemographic covariates, and patient age group, sex, and race and ethnicity. Patients aged 18 to 75 years with 1 or more VHA primary care, emergency department, or mental health visit and no hospice\/palliative care within a given calendar year were included. Time-varying yearly state control covariates were state\/year rates from American Community Survey data: percentage male, Black, Hispanic, White, 18 years or older, unemployed, income below poverty threshold, and yearly median household income. Analysis took place between February to December 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230002-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      As preplanned,\n                      <jats:italic>International Classification of Diseases, Clinical Modification,<\/jats:italic>\n                      ninth and tenth revisions, CUD diagnoses from electronic health records were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230002-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The number of individuals analyzed ranged from 3\u202f234\u202f382 in 2005 to 4\u202f579\u202f994 in 2019. Patients were largely male (94.1% in 2005 and 89.0% in 2019) and White (75.0% in 2005 and 66.6% in 2019), with a mean (SD) age of 57.0 [14.4] years. From 2005 to 2019, adjusted CUD prevalences increased from 1.38% to 2.25% in states with no cannabis laws (no CLs), 1.38% to 2.54% in MCL-only enacting states, and 1.39% to 2.56% in RCL-enacting states. Difference-in-difference results indicated that MCL-only enactment was associated with a 0.05% (0.05-0.06) absolute increase in CUD prevalence, ie, that 4.7% of the total increase in CUD prevalence in MCL-only enacting states could be attributed to MCLs, while RCL enactment was associated with a 0.12% (95% CI, 0.10-0.13) absolute increase in CUD prevalence, ie, that 9.8% of the total increase in CUD prevalence in RCL-enacting states could be attributed to RCLs. The role of RCL in the increases in CUD prevalence was greatest in patients aged 65 to 75 years, with an absolute increase of 0.15% (95% CI, 0.13-0.17) in CUD prevalence associated with RCLs, ie, 18.6% of the total increase in CUD prevalence in that age group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230002-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study of VHA patients, MCL and RCL enactment played a significant role in the overall increases in CUD prevalence, particularly in older patients. However, consistent with general population studies, effect sizes were relatively small, suggesting that cumulatively, laws affected cannabis attitudes diffusely across the country or that other factors played a larger role in the overall increases in adult CUD. Results underscore the need to screen for cannabis use and CUD and to treat CUD when it is present.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2023.0019","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T11:01:07Z","timestamp":1677668467000},"page":"380","source":"Crossref","is-referenced-by-count":54,"title":["State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019"],"prefix":"10.1001","volume":"80","author":[{"given":"Deborah S.","family":"Hasin","sequence":"first","affiliation":[{"name":"Columbia University and New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie M.","family":"Wall","sequence":"additional","affiliation":[{"name":"Columbia University and New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Jean","family":"Choi","sequence":"additional","affiliation":[{"name":"Mental Health Data Science, New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Alschuler","sequence":"additional","affiliation":[{"name":"Mental Health Data Science, New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Malte","sequence":"additional","affiliation":[{"name":"Health Services Research & Development (HSR&D) Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington"},{"name":"Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[{"name":"Columbia University and New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Keyes","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimie L.","family":"Gradus","sequence":"additional","affiliation":[{"name":"Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[{"name":"New York University, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Maynard","sequence":"additional","affiliation":[{"name":"VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomeh","family":"Keyhani","sequence":"additional","affiliation":[{"name":"San Francisco VA Health System and University of California at San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia S.","family":"Martins","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Fink","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Livne","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Mannes","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sherman","sequence":"additional","affiliation":[{"name":"VA Manhattan Harbor Healthcare and New York University, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[{"name":"VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"yoi230002r1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/npp.2017.198","article-title":"US epidemiology of cannabis use and associated problems.","volume":"43","author":"Hasin","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"yoi230002r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106479","article-title":"What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis.","volume":"109","author":"Leung","year":"2020","journal-title":"Addict Behav"},{"issue":"8","key":"yoi230002r3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale.","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"pt B","key":"yoi230002r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109137","article-title":"Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults.","volume":"229","author":"Gutkind","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"yoi230002r6","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jvs.2020.07.094","article-title":"Cannabis use disorder and perioperative outcomes in vascular surgery.","volume":"73","author":"McGuinness","year":"2021","journal-title":"J Vasc Surg"},{"key":"yoi230002r7","doi-asserted-by":"publisher","DOI":"10.1177\/21925682221093965","article-title":"Cannabis use disorder is associated with longer in-hospital lengths of stay, higher rates of medical complications, and costs of care following primary 1- to 2-level lumbar fusion.","author":"Jain","journal-title":"Global Spine J"},{"issue":"1","key":"yoi230002r8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13181-016-0595-z","article-title":"Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment-a systematic review.","volume":"13","author":"Sorensen","year":"2017","journal-title":"J Med Toxicol"},{"key":"yoi230002r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.05.008","article-title":"Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.","volume":"204","author":"Compton","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"yoi230002r10","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi230002r11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/08897077.2021.1944956","article-title":"Time-trends in hospitalizations with cannabis use disorder: a 17-year U.S. national study.","volume":"43","author":"Singh","year":"2022","journal-title":"Subst Abus"},{"issue":"4","key":"yoi230002r12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1037\/a0027622","article-title":"Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009.","volume":"9","author":"Bonn-Miller","year":"2012","journal-title":"Psychol Serv"},{"issue":"10","key":"yoi230002r13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.22010034","article-title":"Trends in cannabis use disorder diagnoses in the U.S. Veterans Health Administration, 2005-2019.","volume":"179","author":"Hasin","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"10","key":"yoi230002r14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S2215-0366(16)30208-5","article-title":"Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys.","volume":"3","author":"Compton","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"yoi230002r15","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1111\/jgs.v69.9","article-title":"Decreasing perceived risk associated with regular cannabis use among older adults in the United States from 2015 to 2019.","volume":"69","author":"Han","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"yoi230002r16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bpsc.2020.12.016","article-title":"A comprehensive review of cannabis potency in the United States in the last decade.","volume":"6","author":"ElSohly","year":"2021","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"2","key":"yoi230002r17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamapsychiatry.2019.3254","article-title":"Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016.","volume":"77","author":"Cerd\u00e1","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"yoi230002r18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/00952990.2019.1569668","article-title":"Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings.","volume":"45","author":"Hasin","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"key":"yoi230002r19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugalcdep.2016.10.004","article-title":"State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population.","volume":"169","author":"Martins","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"yoi230002r20","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/add.v117.6","article-title":"A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17.","volume":"117","author":"Weinberger","year":"2022","journal-title":"Addiction"},{"key":"yoi230002r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108364","article-title":"Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017.","volume":"218","author":"Kim","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"yoi230002r22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jamapsychiatry.2017.0724","article-title":"US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013.","volume":"74","author":"Hasin","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"15","key":"yoi230002r25","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1007\/s11606-021-07370-8","article-title":"Non-pharmacological treatment for chronic pain in us veterans treated within the Veterans Health Administration: implications for expansion in US healthcare systems.","volume":"37","author":"Mannes","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"1","key":"yoi230002r26","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.18m02350","article-title":"US Veterans who do and do not utilize veterans affairs health care services: demographic, military, medical, and psychosocial characteristics.","volume":"21","author":"Meffert","year":"2019","journal-title":"Prim Care Companion CNS Disord"},{"issue":"5","key":"yoi230002r27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/archinte.167.5.476","article-title":"Bringing the war back home: mental health disorders among 103,788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities.","volume":"167","author":"Seal","year":"2007","journal-title":"Arch Intern Med"},{"issue":"4","key":"yoi230002r29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/1077558715617382","article-title":"Do Veterans Health Administration enrollees generalize to other populations?","volume":"73","author":"Wong","year":"2016","journal-title":"Med Care Res Rev"},{"issue":"1","key":"yoi230002r30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1186\/s12913-022-08899-y","article-title":"Comparing mental and physical health of U.S. veterans by VA healthcare use: implications for generalizability of research in the VA electronic health records.","volume":"22","author":"Fink","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"yoi230002r31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the national epidemiologic survey on alcohol and related conditions-III.","volume":"173","author":"Hasin","year":"2016","journal-title":"Am J Psychiatry"},{"key":"yoi230002r32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.10.042","article-title":"The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014.","volume":"170","author":"Carliner","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"yoi230002r34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6511a1","article-title":"National estimates of marijuana use and related indicators: National Survey on Drug Use and Health, United States, 2002-2014.","volume":"65","author":"Azofeifa","year":"2016","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"yoi230002r35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jamainternmed.2019.7517","article-title":"Trends in cannabis use among older adults in the United States, 2015-2018.","volume":"180","author":"Han","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"yoi230002r40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jeconom.2020.10.012","article-title":"Design-based analysis in difference-in-differences settings with staggered adoption.","volume":"226","author":"Athey","year":"2022","journal-title":"J Econom"},{"issue":"4","key":"yoi230002r41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/ADM.0000000000000593","article-title":"Differences in opinions about marijuana use and prevalence of use by state legalization status.","volume":"14","author":"Steigerwald","year":"2020","journal-title":"J Addict Med"},{"issue":"12","key":"yoi230002r43","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1111\/add.v112.12","article-title":"Potency increase, product development and marijuana marketing in times of legalization.","volume":"112","author":"Carlini","year":"2017","journal-title":"Addiction"},{"issue":"23","key":"yoi230002r44","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1001\/jama.2021.21182","article-title":"Heterogeneous state cannabis policies: potential implications for patients and health care professionals.","volume":"326","author":"Incze","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"yoi230002r45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.15288\/jsad.2022.83.27","article-title":"A Content analysis of cannabis company adherence to marketing requirements in four states.","volume":"83","author":"Moreno","year":"2022","journal-title":"J Stud Alcohol Drugs"},{"issue":"1","key":"yoi230002r46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13011-021-00359-w","article-title":"Cyber-ethnography of cannabis marketing on social media.","volume":"16","author":"Jenkins","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"7","key":"yoi230002r47","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16551","article-title":"Compliance with cannabis act regulations regarding online promotion among canadian commercial cannabis-licensed firms.","volume":"4","author":"Sheikhan","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"yoi230002r48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.15288\/jsad.2022.83.18","article-title":"Cannabis industry marketing violations in Washington State, 2014-2019.","volume":"83","author":"Carlini","year":"2022","journal-title":"J Stud Alcohol Drugs"},{"issue":"7","key":"yoi230002r49","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1176\/appi.ajp.2019.19030284","article-title":"U.S. adults with pain, a group increasingly vulnerable to nonmedical cannabis use and cannabis use disorder: 2001-2002 and 2012-2013.","volume":"177","author":"Hasin","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"7","key":"yoi230002r50","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jpain.2019.01.003","article-title":"Eighteen-year trends in the prevalence of, and health care use for, noncancer pain in the United States: data from the Medical Expenditure Panel Survey.","volume":"20","author":"Nahin","year":"2019","journal-title":"J Pain"},{"issue":"5","key":"yoi230002r51","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/add.v115.5","article-title":"Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions.","volume":"115","author":"Pacek","year":"2020","journal-title":"Addiction"},{"issue":"5","key":"yoi230002r52","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/add.v116.5","article-title":"Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.","volume":"116","author":"Freeman","year":"2021","journal-title":"Addiction"},{"issue":"15","key":"yoi230002r53","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1017\/S0033291715001178","article-title":"Examining the profile of high-potency cannabis and its association with severity of cannabis dependence.","volume":"45","author":"Freeman","year":"2015","journal-title":"Psychol Med"},{"key":"yoi230002r54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.copsyc.2019.04.002","article-title":"Changing landscape of cannabis: novel products, formulations, and methods of administration.","volume":"30","author":"Spindle","year":"2019","journal-title":"Curr Opin Psychol"},{"issue":"6","key":"yoi230002r55","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/dar.v40.6","article-title":"Advancing the science on cannabis concentrates and behavioural health.","volume":"40","author":"Bidwell","year":"2021","journal-title":"Drug Alcohol Rev"},{"key":"yoi230002r57","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.893009","article-title":"Association of tetrahydrocannabinol content and price in herbal cannabis products offered by dispensaries in California: a purview of consumers\/patients.","volume":"10","author":"Dobbins","year":"2022","journal-title":"Front Public Health"},{"key":"yoi230002r58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/publhealth.2016.37.issue-1","article-title":"Using electronic health records for population health research: a review of methods and applications.","volume":"37","author":"Casey","year":"2016","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"yoi230002r59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ajad.12319","article-title":"The epidemiology of substance use disorders in US Veterans: a systematic review and analysis of assessment methods.","volume":"25","author":"Lan","year":"2016","journal-title":"Am J Addict"},{"issue":"10","key":"yoi230002r60","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.22010034","article-title":"Trends in cannabis use disorder diagnoses in the U.S. Veterans Health Administration, 2005-2019.","volume":"179","author":"Hasin","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi230002r62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pam.2015.34.issue-1","article-title":"Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details.","volume":"34","author":"Pacula","year":"2015","journal-title":"J Policy Anal Manage"},{"issue":"3","key":"yoi230002r63","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.2545","article-title":"Cannabis policy heterogeneity and effects on research-complexity expected.","volume":"4","author":"Johnson","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"yoi230002r64","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/add.v115.6","article-title":"Commentary on Bae & Kerr (2020): recreational marijuana legalization-we need to think about heterogeneity of policy effects.","volume":"115","author":"Cerd\u00e1","year":"2020","journal-title":"Addiction"},{"key":"yoi230002r65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpubeco.2020.104159","article-title":"Federalism, partial prohibition, and cross-border sales: evidence from recreational marijuana.","volume":"187","author":"Hansen","year":"2020","journal-title":"J Public Econ"},{"issue":"1","key":"yoi230002r66","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/economics.2018.10.issue-1","article-title":"Econometric methods for program evaluation.","volume":"10","author":"Abadie","year":"2018","journal-title":"Annu Rev Econ"},{"issue":"1","key":"yoi230002r67","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1146\/economics.2022.14.issue-1","article-title":"The Econometric model for causal policy analysis.","volume":"14","author":"Heckman","year":"2022","journal-title":"Annu Rev Econ"},{"key":"yoi230002r68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jclinepi.2017.03.012","article-title":"Quasi-experimental study designs series-paper 4: uses and value.","volume":"89","author":"B\u00e4rnighausen","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"yoi230002r69","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2105\/AJPH.2018.304392","article-title":"The C-word: the more we discuss it, the less dirty it sounds.","volume":"108","author":"Hern\u00e1n","year":"2018","journal-title":"Am J Public Health"},{"issue":"4","key":"yoi230002r70","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/ALN.0000000000003067","article-title":"Cannabis use disorder and perioperative outcomes in major elective surgeries: a retrospective cohort analysis.","volume":"132","author":"Goel","year":"2020","journal-title":"Anesthesiology"},{"issue":"2","key":"yoi230002r71","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1037\/0022-006X.74.2.307","article-title":"Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence.","volume":"74","author":"Budney","year":"2006","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"yoi230002r72","doi-asserted-by":"publisher","first-page":"468","DOI":"10.7326\/0003-4819-123-6-199509150-00013","article-title":"Perception and regulation of drug use: the rise and fall of the tide.","volume":"123","author":"Musto","year":"1995","journal-title":"Ann Intern Med"},{"key":"yoi230002r4","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"yoi230002r23","unstructured":"U.S. Department of Veteran Affairs. About VHA. https:\/\/www.va.gov\/health\/aboutvha.asp. Published 2022. Accessed June 24, 2022."},{"key":"yoi230002r24","unstructured":"U.S. Department of Veteran Affairs. Expenditures. Updated August 15, 2022. Accessed November 16, 2022. https:\/\/www.va.gov\/vetdata\/expenditures.asp"},{"key":"yoi230002r28","unstructured":"Vespa? J. Those who served: America\u2019s veterans From World War II to the war on terror. United States Census Bureau. Published June 2, 2020. Accessed June 24, 2022. https:\/\/www.census.gov\/library\/publications\/2020\/demo\/acs-43.html"},{"key":"yoi230002r33","unstructured":"Wang? J, Cidade? M, Larsen? M, Pearman? G, Schimpf? M, Dhanireddy? P. 2018 Survey of veteran enrollees' health and use of health care. Advanced Survey Design, LLC. Accessed June 24, 2022. https:\/\/www.va.gov\/health\/survey.asp"},{"key":"yoi230002r36","unstructured":"RAND Corporation. OPTIC-vetted policy data sets. Accessed June 24, 2022. https:\/\/www.rand.org\/health-care\/centers\/optic\/resources\/datasets.html"},{"key":"yoi230002r37","unstructured":"United States Census Bureau. American Community Survey 1-year data (2005-2021). Accessed June 24, 2022. https:\/\/www.census.gov\/data\/developers\/data-sets\/acs-1year.html"},{"key":"yoi230002r38","unstructured":"United States Census Bureau. American Community Survey 5-year data (2009-2019). Accesssed June 24, 2022. https:\/\/www.census.gov\/data\/developers\/data-sets\/acs-5year.html"},{"key":"yoi230002r39","unstructured":"tidycensus: Load US census boundary and attribute data as 'tidyverse' and 'sf'-ready data frames. Accesssed June 24, 2022. https:\/\/cran.r-project.org\/web\/packages\/tidycensus\/index.html"},{"key":"yoi230002r42","unstructured":"Klein? H, Bentivegna? MC. Cannabis industry trends for 2022. Eisner Advisory Group LLC. Published April 19, 2022. Accessed June 24, 2022. https:\/\/www.eisneramper.com\/cannabis-trends-0422\/"},{"key":"yoi230002r56","unstructured":"Schaneman? B. Marijuana concentrate sales up 40% as more consumers turn to the product category. MJBiz. Updated December 17, 2021. Accessed July 6, 2022. https:\/\/mjbizdaily.com\/marijuana-concentrate-sales-up-40-percent-as-more-consumers-turn-to-the-product-category\/"},{"key":"yoi230002r61","unstructured":"Center for Behavioral Health Statistics and Quality. Table 5.1B\u2013substance use disorder for specific substances in past year among persons aged 12 or older, by age group: percentages, 2018 and 2019. Substance Abuse and Mental Health Services Administration. Accessed June 24, 2022. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt29394\/NSDUHDetailedTabs2019\/NSDUHDetTabsSect5pe2019.htm"},{"key":"yoi230002r73","unstructured":"Johnston? LD, O\u2019Malley? PM, Bachman? JG. Monitoring the future: national survey results on drug use, 1975-1999: volume I, secondary school students. National Institute on Drug Abuse. Accessed June 24, 2022. https:\/\/monitoringthefuture.org\/wp-content\/uploads\/2022\/08\/mtf-vol1_1999.pdf"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2801971\/jamapsychiatry_hasin_2023_oi_230002_1716917459.16121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T11:01:56Z","timestamp":1716980516000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2801971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.0019","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}